Skip to main content

Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 18, 2023 -- Patients with chronic hepatitis C virus (HCV) who do not respond to hepatitis B virus (HBV) vaccine should undergo revaccination after HCV treatment and eradication, according to a study published online July 31 in The Journal of Infectious Diseases.

Noting that patients with chronic HCV do not respond to HBV vaccination as efficiently as the general population, Jesse G. Powell, from Hennepin Healthcare in Minneapolis, and colleagues examined whether revaccination after HCV treatment improves response. Previous HBV vaccine nonresponders were recruited for revaccination after HCV eradication.

Thirty-one of 34 enrolled patients underwent follow-up hepatitis B surface antibody (HBsAb) testing one month after vaccine series completion. The researchers found that 21 of the patients (67.7 percent) produced a reactive HBsAb, eight were nonreactive, and two had equivocal results (25.8 and 6.5 percent, respectively). No significant differences were seen in HBsAb reactivity according to age, sex, race, or presence of advanced fibrosis.

"This study has broad implications for public health in hepatitis-infected individuals," coauthor Jose Debes, M.D., Ph.D., from the University of Minnesota in Minneapolis, said in a statement. "It is known that the hepatitis B vaccine is not as effective in those with hepatitis C. What was not known until now is that after treating hepatitis C the hepatitis B vaccine seems to be more effective in this population. This is important as many of these individuals are still at risk for hepatitis B infection."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk

TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...

Most Moms-to-Be Interested in RSV Vaccination During Pregnancy

THURSDAY, April 25, 2024 -- More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV)...

2011 to 2021 Saw Increase in Vaccination Timeliness for Infants

MONDAY, April 15, 2024 -- From 2011 to 2021, there was an increase in vaccination timeliness among U.S. children aged 0 to 19 months, according to a study published online April...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.